Dr. David Soria speaks about a new study published in the British Medical Journal Open that says prescription strength, proton-pump inhibitors are associated with a potential 25 percent increased risk of early death from any cause.
At prescription strength, proton-pump inhibitors are associated with a potential 25% increased risk of early death from any cause, suggests new research published Monday in the British Medical Journal Open.
Posted
4:23 PM, Jul 05, 2017
Copyright 2016 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
